NEU 5.48% $22.14 neuren pharmaceuticals limited

Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-11

  1. 2,831 Posts.
    lightbulb Created with Sketch. 592
    Long-termers (such as myself) would know that there has been speculation at various times over the years, that NEU would be taken-over.

    I'd argued against that and statements from the company subsequently ruled that out until the phase 3 results (at the earliest).

    If trofinetide is approved, it would seem to me that it is almost certain that Acadia would make us an offer.

    There has been chatter also that Baker Bros might be positioning Acadia for a sale. Approval of trofinetide would help if that was the case.

    Maybe the SP action over the next 4 months might give us a hint as to either of those two possibilities playing out?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$22.14
Change
1.150(5.48%)
Mkt cap ! $2.829B
Open High Low Value Volume
$21.50 $22.44 $21.50 $13.15M 598.8K

Buyers (Bids)

No. Vol. Price($)
1 437 $22.12
 

Sellers (Offers)

Price($) Vol. No.
$22.15 8325 7
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.